• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Tandem stock ticks up after Wells Fargo upgrade

November 15, 2022 By Sean Whooley

Tandem Diabetes CareTandem Diabetes Care (Nasdaq:TNDM) shares ticked up today after Wells Fargo declared it “Equal Weight,” an improvement from “Underweight.”

Shares of TNDM rose 8.3% at $42.81 apiece in midday trading today. MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 6.8%.

According to a report from SeekingAlpha, Wells Fargo’s update claims estimates for Tandem reached a “more realistic” level despite drops in its valuation. This news follows Tandem’s third-quarter results that missed the consensus forecast earlier this month. The company’s earnings report brought its stock down significantly as the company reduced its full-year guidance, too.

However, the past few days brought positive news for the company. Last week, Tandem said a study of adults with type 2 diabetes supported its t:slim X2 automated insulin delivery system. Patients achieved improvement in all clinical endpoints with the technology, which currently does not hold approval for type 2 diabetes. Now, Wells Fargo analyst Larry Biegelsen and colleagues gave Tandem a further boost with this upgrade.

Analysts wrote that, despite improved outlooks on the company, challenges remain. They expect Tandem to be faced with adding new patient starts with competition from Insulet’s Omnipod 5 and Medtronic’s MiniMed 780G.

Omnipod 5 holds FDA approval but faced a slight setback recently. Insulet announced yesterday that it issued a medical device correction related to an issue with the Omnipod 5 controller’s charging port and cable.

Recent study data supports the Medtronic next-generation MiniMed 780G, but it still hasn’t garnered FDA clearance. It picked up Health Canada licensing earlier this month and the company today launched an extended infusion set for its MiniMed 600 and 700 series pumps.

However, Wells Fargo said questions remain over the timeline for U.S. approval given a September warning on cybersecurity issues with MiniMed pumps.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

IN CASE YOU MISSED IT

  • Dexcom updates CGM receiver recall that led to serious adverse events
  • Abbott reports momentum with Libre CGM business as new dual sensor will ‘accelerate’ growth
  • Johnson & Johnson wins FDA priority review for drug delivery system
  • Glucose monitoring company LifeScan files chapter 11 to reduce debt
  • Medtronic enrolls first patient in study for Onyx liquid embolic system

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS